Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IGO LIMITED Director's Dealing 2021

Jan 26, 2021

65111_rns_2021-01-26_73d32bbf-9284-4f6a-bb36-c5bebef284ab.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

27 January 2021

APPENDIX 3Y CHANGE OF DIRECTOR’S INTEREST NOTICE

IGO Limited (ASX:IGO) ( IGO or the Company ) attaches an Appendix 3Y (Change of Director’s Interest Notice) for Dr Xiaoping Yang in relation to a recent purchase of the Company’s securities by Dr Yang.

The trade the subject of the attached Appendix 3Y occurred on 19 January 2021. The Company only became aware of the trade on, 25 January 2021 and due to verifying details of the holding was only able to announce the transaction today.

The trade occurred after the end of the December quarter and before the release of the Company’s December Activities Report and the release of the Company’s half-yearly results, meaning that Dr Yang acquired IGO securities during a notified ‘blackout period’ under the Company's ‘Dealing in Securities Standard’ dated 24 March 2020 ( Trading Policy ). The trade did not fall under any of the exceptions listed in the Trading Policy.

Dr Yang has confirmed to the Board of IGO that she was not in possession of any price sensitive or inside information when she effected the trade, and that the trade related to a small number of securities (only 100 IGO shares).

Dr Yang has advised that the trade occurred as a result of personal oversight. She was recently appointed to the Board of IGO on 1 December 2020, at which point she was provided with all materials applicable to her appointment ( Appointment Materials ), including the Trading Policy. Dr Yang confirmed that she had read and understood the Appointment Materials, including the Trading Policy, prior to effecting the trade.

The Company considers that it has a high level of corporate governance arrangements in place and that this incident occurred as a matter of personal oversight by Dr Yang. These corporate governance arrangements include:

  • All IGO Directors, including Dr Yang, are frequently reminded of their obligations under ASX Listing Rule 3.19A and the Trading Policy.

  • The Company Secretary provides written notice to the IGO Directors and other ‘restricted persons’ advising when the Company is about to enter a ‘blackout period’. The last such notice was emailed to directors and other restricted persons on 22 December 2020 and remains current.

  • Irrespective of whether the Company is in a ‘blackout period’, all IGO Directors must obtain authority from the Chair prior to dealing in IGO shares.

Dr Yang has been advised that any further breaches of the Company’s policies may result in disciplinary action being taken (depending on the circumstances at the time).

Joanne McDonald

Company Secretary and Head of Corporate Affairs

IGO Limited

This announcement has been authorised for release to the ASX by the Company Secretary.

PO Box 496 South Perth WA 6951 Western Australia

Suite 4, Level 5 85 South Perth Esplanade South Perth WA 6151

T. +61 8 9238 8300 igo.com.au F. +61 8 9238 8399 IGO Limited E. [email protected] ABN 46 092 786 304

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity: IGO LIMITED ABN: 46 092 786 304

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

We (the entity) give ASX the followingthe director for the purposes of section information under listing rule 3.19A.2 and as agent for205G of the Corporations Act.
Name of Director XIAOPING YANG
Date of last notice 1 December 2020

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Direct
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to therelevant interest.
Date of change 19 January 2021
No. of securities held prior to change -
Class Ordinary shares fully paid
Number acquired 100
Number disposed -
Value/ConsiderationNote: If consideration is non-cash, provide details andestimated valuation US$609.00
No. of securities held after changeXiaoping Yang 100 ordinary shares fully paid
Nature of changeExample: on-market trade, off-market trade, exercise ofoptions, issue of securities under dividend reinvestment plan,participation in buy-back On-market trade
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract n/a
Nature of interest n/a
Name of registered holder n/a
(if issued securities)
Date of change n/a
No. and class of securities to which n/a
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
Interest acquired n/a
Interest disposed n/a
Value/Consideration n/a
Note: If consideration is non-cash, provide details
and an estimated valuation
Interest after change n/a

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed Yes
above traded during a+closed period where prior written
clearance was required?
If so, was prior written clearance provided to allow the trade No (please see cover letter
to proceed during this period? attached to this Appendix 3Y for
further details)
If prior written clearance was provided, on what date was this n/a
provided?
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011